TSHR and thyrotoxicosis: The disease is characterized by the presence of thyroid-stimulating antibodies (TSAb) that target the thyroid-stimulating hormone receptor (TSHR) and act as agonists, leading to chronic hyperstimulation and thyrotoxicosis [3].